Search results for Ulocuplumab
Ulocuplumab Biosimilar – Anti-CXCR4, CD184 mAb – Research Grade, ProteoGenix, PX-TA1339
Description of Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade General information on Anti-CXCR4/CD184[Homo sapiens] (Ulocuplumab) Monoclonal Antibody Ulocuplumab is investigated for the treatment of Solid Tumors.
Host
Reactivity
Applications
Conjugation
Ulocuplumab, Abbexa, abx831298
Ulocuplumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CXCR4/CD184, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Ulocuplumab Biosimilar - Research Grade, ichor.bio, ICH5954
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Ulocuplumab Vedotin Biosimilar - Research Grade, ichor.bio, ICH5954V
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.